(Q42635142)

4 November 2017

title

Desensitizing the broadly human leukocyte antigen-sensitized patient awaiting deceased donor kidney transplantation (English)

1 reference

4 November 2017

S C Jordan

1

1 reference

4 November 2017

N Reinsmoen

2

1 reference

4 November 2017

C-H Lai

3

1 reference

4 November 2017

K Cao

4

1 reference

4 November 2017

J Kahwaji

5

1 reference

4 November 2017

A Peng

6

1 reference

4 November 2017

R Villicana

7

1 reference

4 November 2017

A Vo

8

1 reference

4 November 2017

language of work or name

English

0 references

publication date

1 January 2012

1 reference

Transplantation Proceedings

4 November 2017

published in

1 reference

4 November 2017

volume

44

1 reference

4 November 2017

issue

1

1 reference

4 November 2017

page(s)

60-61

1 reference

Comparison of survival probabilities for dialysis patients vs cadaveric renal transplant recipients

4 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.12.028

Reducing antibody levels in patients undergoing transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.12.028

The use of immunoglobulin therapy for patients undergoing solid organ transplantation: an evidence-based practice guideline.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.12.028

Acceptable donor-specific antibody levels allowing for successful deceased and living donor kidney transplantation after desensitization therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.12.028

Antibody testing strategies for deceased donor kidney transplantation after immunomodulatory therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.12.028

Rituximab and intravenous immune globulin for desensitization during renal transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.12.028

Use of intravenous immune globulin and rituximab for desensitization of highly HLA-sensitized patients awaiting kidney transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.12.028

Infectious complications in kidney-transplant recipients desensitized with rituximab and intravenous immunoglobulin

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2011.12.028

10.1016/J.TRANSPROCEED.2011.12.028

7 January 2021

Identifiers

DOI

1 reference

4 November 2017

1 reference